Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

MagIndustries (T.MAA) up 12% on China funding news

Top Bullboards post: “Wow. I feel so sorry for those that have braved this nasty story . Myself included. I honestly thought this was it for all of you. I will disclose I have no interest in this company any longer and no I do not have any inside knowledge,&CloseCurlyQu...
Stockhouse Editorial | November 21, 2013 |

Best Microcap Stocks

Some market components, such as small capitalization companies, require a little persuasion. Whether it’s their potential to produce incredible gains, or the chance to get in early on a growing industry, small-cap stocks present enticing opportunities. While ...
Stockhouse Editorial | June 4, 2019 |

Navidea Shares Jump 60% on Phase 2b Rheumatoid Arthritis Trial Results

Shares of Navidea Biopharmaceuticals traded 60% higher today on extremely high relative volume after the firm released data from its Phase 2b Rheumatoid Arthritis Tc 99m Tilmanocept Planar Imaging study. Developer of precision immunodiagnostic agents and immunotherape...
Streetwise Reports | October 30, 2019 |

Biotech's 'Multiple Sclerosis Therapy Shows Improvement in Disability'

Atara Biotherapeutics' clinical trial design and results are reviewed in a ROTH Capital Partners report. In a May 26 research note, ROTH Capital Partners analyst Tony Butler purported that Atara Biotherapeutics Inc.'s (ATRA:NASDAQ) "updated data from the Phase 1 ...
Streetwise Reports | May 28, 2020 |

Is Extreme Vehicle Battery Technologies Corp. Positioning to be the Next Big Clean Energy Stock?

On April 12, Extreme Vehicle Battery Technologies Corp. ( CSE: ACDC , OTC: CRYBF , Forum ) published its latest press release that helped to answer a lot of questions that have been on the minds of investors. In the press release, the company discussed its addition to...
Featured Submission | April 19, 2021 |

History Says Stocks Can Perform Very Well After Big Oil Shocks

HOW CONCERNING IS THE RECENT SPIKE IN OIL PRICES? Monday’s news was filled with blurbs similar to the one below from CNBC: “Stocks fell on Monday amid fears that a surge in oil prices following an attack in Saudi Arabia could slow down global economic g...
Chris Ciovacco | September 18, 2019 |

The Road Ahead May Be Brighter Than Expectations

THE BIG PICTURE Recent data seems to cast doubt on the seemingly never-ending call for an imminent recession. From a September 20, 2019 Bloomberg article: “The U.S. economy is outperforming expectations by the most this year, offering a fresh rebuttal to last month&C...
Chris Ciovacco | September 24, 2019 |

New Gold & Silver Bull Analogs

Back during the bear market years (it’s nice to be able to write that now), I regularly would compare the declines in Gold, Silver and gold stocks to their past history. It gave us a visual representation of just how bad the forever bear market was and helped u...
Jordan Roy-Byrne, CMT | August 27, 2019 |

StockTalk Exclusive! Cannabis Industry Icon Steve DeAngelo

Steve DeAngelo chats with Cindy Broad for the Arcview 2020 Vision Series First Forum: Cannabis Investing for a New Decade. Listen to Steve's colourful commentary on everything from surviving the dip, to what's next for the industry, to his views on psychedelics......
Cindy Broad | February 11, 2020 |

Ximen Mining ESG Reporting: Kenville Gold Mine Hydrogeology

(Click to watch video) As part of a continued commitment to ESG reporting, Ximen Mining is pleased to share summarized results from a hydrogeology assessment completed for the Company’s 100% owned Kenville Gold Mine project in Nelson, southea...
Featured Submission | July 29, 2021 |
1 2 3 4 5 6 7 8 9 10 ...